體外診斷(IVD)裝置︰ 2013年及2018年美國產業預測 是由出版商The Freedonia Group在2009年03月所出版的。
這份英文市場調查報告書包含373 PAGES 價格從美金4800起跳。
Abstract
US demand to rise 5.4% annually through 2013
The US market for in vitro diagnostic (IVD) products will increase 5.4 percent
annually to $23 billion in 2013. Clinical chemistry and immunoassay methods
will remain the top two IVD sciences: the former based on sales of blood
glucose monitors and test strips; the latter due to the penetration of high
value-added chemiluminescent products into infectious disease and drug testing
markets. Nucleic acid testing products will generate the fastest demand gains
among IVD products based on throughput, sensitivity, accuracy and speed
advantages, especially in the detection of infectious diseases and cancer
markers. Because of increasing blood glucose monitoring among diabetic
patients, endocrine condition testing will remain the largest IVD application
in 2013 and beyond.
Evolving trends, methods to benefit most IVD products
Evolving epidemiological trends and patient care approaches will impact
favorably on growth opportunities for most types of IVD products. The market
for clinical chemistry reagents and instruments will benefit from more
diabetic patients engaging in self-blood glucose monitoring and from the
expanding use of general health screening in routine patient examinations. The
widening availability of chemiluminescent tests with inherent sensitivity and
selectivity advantages will broaden applications for immunoassays in
monitoring therapeutic drugs, detecting drugs of abuse and testing infectious
diseases.
Due to their ability to quantify heart attack and embolism risk prior to
occurrence, hemostasis tests for D-Dimer and other cardiac parameters will
provide the best growth opportunities among IVD blood testing products. Demand
for nucleic acid diagnostics will expand at a strong pace as next-generation
PCR (polymerase chain reaction) and microarray technologies penetrate
applications involving the analysis and characterization of complex infections
and tumors. DNA-based forensic, genetic and identity testing will comprise the
fastest growing IVD application through 2013 as revenues from law enforcement
and genetic screening markets rise. Among other IVD products, cellular
analysis and anatomical pathology reagents and instruments will post the
fastest gains in demand. Cellular analysis techniques will continue to
dominate cervical cancer testing and penetrate additional cancer diagnostic
applications. Anatomical pathology will remain the leading IVD technique for
biopsy-based cancer/disease detection.
Hospital labs to remain largest IVD product market
Hospital laboratories will continue to comprise the largest market for IVD
products because of extensive inpatient, emergency and post-surgical testing
activities. The upgrading of testing services will keep independent clinical
laboratories the second largest overall and fastest growing professional
market served by the IVD industry. Noninstitutional point of care segments,
consisting of physicians' offices and outpatient clinics, will see below
average gains in IVD product demand due to the low value-added nature of tests
conducted and competition from hospital and independent clinical laboratories.
Home health care will comprise the fasting growing IVD market through 2013,
based on the expansion of self-blood glucose monitoring by diabetic patients.
However, except for diabetes testing, the home health care market will remain
relatively small due to the lack of cost effective products for self-use.
Study coverage
This new Freedonia industry study, In Vitro Diagnostics, presents
historical demand data (1998, 2003, 2008) plus forecasts for 2013 and 2018 by
IVD product type, methodology, application and market. The study also
considers key US market environment factors, evaluates market share data and
profiles industry players.
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Environment
- Population & Demographic Trends
- Health Care Trends
- Acute Conditions
- Chronic Conditions
- Cancer & AIDS
- Health Insurance Trends
- National Health Expenditures
- Medical Providers
- Acute Care Hospitals
- Physicians
- Outpatient Facilities
- Patient Activity
- Hospital Activity
- Surgical Procedures
- Outpatient & Home Health Care Activity
- IVD Product Overview
- Regulation
- Technology
- Diagnostic Testing Volume
- Clinical Laboratory Testing Services
- Pricing Trends
- Product Demand Patterns, 1998-2008
- US Trade
- International Markets
III. IVD PRODUCTS
- General
- Product Segments
- Reagents & Consumables
- Instruments & Systems
- Clinical Chemistry Products
- Professional Products
- Reagents & Test Kits
- Blood Glucose
- Lipids
- Electrolytes & Blood Gases
- Proteins
- Enzymes
- Toxicology Reagents
- Other Clinical Chemistry Reagents
- Standards & Controls
- Instruments & Systems
- Applications
- Producers
- Self-Testing Products
- Blood Glucose Monitoring Products
- Test Strips & Discs
- Monitors
- Other Self-Testing Products
- Immunoassay Products
- Technology Overview
- Competitive Immunoassays
- Noncompetitive Immunoassays
- Heterogeneous & Homogeneous Immunoassays
- Labeling Techniques
- Manual Immunoassays
- Reagents & Test Kits
- Enzyme Immunoassays
- Chemiluminescent Immunoassays
- Fluorescent Immunoassays
- Radioimmunoassays
- Instruments & Systems
- Applications
- Drug Testing
- Therapeutic Drugs
- Illicit Drugs
- Infectious Disease Testing
- Endocrine Condition Testing
- Cancer Testing
- Heart Disease Testing
- Other Applications
- Producers
- Blood Testing Products
- Hematology Products
- Reagents & Consumables
- Instruments & Systems
- Applications
- Producers
- Blood Banking Products
- Reagents & Consumables
- Instruments & Systems
- Applications
- Producers
- Hemostasis Products
- Reagents & Consumables
- Instruments & Systems
- Applications
- Producers
- Nucleic Acid Testing Products
- Technology Overview
- Polymerase Chain Reaction (PCR)
- Microarrays
- DNA Sequencing
- In Situ Hybridization (ISH)
- Restriction Fragment Length Polymorphisms (RFLPs)
- Amplified DNA Probes
- Direct DNA Probes
- Instruments & Systems
- PCR Systems
- Microarray Systems
- Microarray Products
- IVD Applications
- Disease Management
- Forensic Medicine
- Illicit Drug Testing
- Consumables
- Applications
- Producers
- Microbiology Products
- Culture Media
- Reagents & Consumables
- Instruments & Systems
- Applications
- Producers
- Cellular Analysis Products
- Flow Cytometry Products
- Reagents & Consumables
- Instruments & Systems
- Applications
- Producers
- Other Cellular Analysis Products
- Reagents & Consumables
- Instruments
- Applications
- Producers
- Other IVD Products
- Anatomical Pathology Products
- Histology Products
- Immunohistochemistry Products
- Effusion & Visual Inspection Products
- Visual Inspection Tests
- Effusion Tests
- Applications
- Producers
- Cytology Products
- Reagents, Supplies & Instruments
- Applications
IV. IVD APPLICATIONS
- General
- Endocrine Conditions
- Diabetes Monitoring Products
- Blood Glucose Test Strips
- Blood Glucose Monitors
- Other Diabetes Monitoring Products
- Hemoglobin A1c
- Microalbumin
- Ketones
- All Other Diabetes IVD Products
- Pregnancy, Ovulation & Fertility Tests
- Other IVD Products for Endocrine Conditions
- Infectious Diseases
- Sexually Transmitted Diseases
- IVD Demand by Methodology
- IVD Demand by Condition
- AIDS/HIV
- Chlamydia
- Herpes
- Gonorrhea
- Other Sexually Transmitted Diseases
- Other Infectious Diseases
- IVD Demand by Methodology
- IVD Demand by Condition
- Hepatitis
- All Other Infectious Diseases
- Cancer
- IVD Demand by Methodology
- IVD Demand by Condition
- Cervical Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Other Cancers
- Drug Testing
- Therapeutic Drug Monitoring (TDM)
- Illicit Drug Testing
- Heart Disease
- Lipid Profiling
- Cardiac Markers
- Blood Proteins
- Blood Grouping & Screening
- Blood Typing & Matching
- Blood & Bleeding Disorders
- Forensic Medicine & Related Testing
- Forensic Testing
- Genetic Testing
- Identity Testing
- General Health Screening & Other IVD Applications
- General Health Screening
- Disease Detection & Other
V. IVD MARKETS
- General
- Hospitals
- Independent Clinical Laboratories
- Home Health Care
- Outpatient Facilities
- Other Markets
VI. INDUSTRY STRUCTURE
- General
- Market Share
- Johnson & Johnson
- Roche Holding
- Siemens Healthcare Diagnostics
- Abbott Laboratories
- Beckman Coulter
- Becton Dickinson
- Competitive Strategies
- Mergers & Acquisitions
- Cooperative Agreements
- Research & Development
- Marketing & Distribution
- Manufacturing
COMPANY PROFILES
- 454 Life Sciences, see Roche
- Abbott Laboratories
- Applied Biosystems Incorporated, see Life Technologies
- Bayer AG
- BD GeneOhm, see Becton Dickinson
- Beckman Coulter Incorporated
- Becton, Dickinson and Company
- Bio-Rad Laboratories Incorporated
- bioMerieux SA
- Biosite Incorporated, see Inverness Medical Innovations
- BioVeris Corporation, see Roche
- Celera Corporation
- Cholestech Corporation, see Inverness Medical Innovations
- Cytopeia Incorporated, see Becton Dickinson
- Cytyc Corporation, see Hologic
- Dade Behring Incorporated, see Siemens
- Danaher Corporation
- Digene Corporation, see QIAGEN
- First Check Diagnostics, see Inverness Medical Innovations
- Gen-Probe Incorporated
- Hologic Incorporated
- Inverness Medical Innovations Incorporated
- Invitrogen Corporation, see Life Technologies
- Johnson & Johnson
- Life Technologies Corporation
- LifeScan Incorporated, see Johnson & Johnson
- Lumigen Incorporated, see Beckman Coulter
- Meridian Bioscience Incorporated
- NimbleGen Systems Incorporated, see Roche
- Olympus Corporation
- Oncogene Science Incorporated, see Siemens
- Ortho-Clinical Diagnostics, see Johnson & Johnson
- QIAGEN NV
- Quidel Corporation
- Redwood Toxicology Laboratory Incorporated, see Inverness Medical
Innovations
- Roche Holding Limited
- Siemens AG
- Swiss Precision Diagnostics, see Inverness Medical
- Innovations
- Sysmex Corporation
- Thermo Fisher Scientific Incorporated
- Third Wave Technologies Incorporated, see Hologic
- Trinity Biotech plc
- TriPath, see Becton Dickinson
- Ventana Medical Systems Incorporated, see Roche
- Veridex LLC, see Johnson & Johnson
- Other Companies Mentioned in the Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- Macroeconomic Indicators
- Population & Demographics
- Acute Conditions by Type
- Chronic Conditions by Type
- Cancer & AIDS Indicators
- Health Insurance Coverage of the US Population, 1998-2008
- National Health Expenditures by Type & Source
- Acute Care Hospitals
- Physicians & Physicians' Offices
- Outpatient Facilities
- Hospital Activity
- Surgical Procedures
- Outpatient & Home Health Care Activity
- Diagnostic Testing Volume
- Clinical Laboratory Testing Sites & Revenues
- IVD Product Demand, 1998-2008
- US Trade in IVD Products
- World IVD Product Demand by Region
SECTION III -- IVD PRODUCTS
- IVD Demand by Product Group
- IVD Product Demand by Methodology
- IVD Reagent & Consumable Demand by Methodology
- IVD Instrument & System Demand by Methodology
- Clinical Chemistry Product Demand by Segment
- Professional Clinical Chemistry Product Demand by Type
- Common Clinical Chemistry Tests
- Professional Clinical Chemistry Product Demand by Application
- Self-Testing Clinical Chemistry Product Demand by Type
- Self-Testing Clinical Chemistry Product Demand by Application
- Immunoassay Product Demand by Type
- Immunoassay Product Demand by Application
- Blood Testing Product Demand by Methodology
- Hematology Product Demand by Type
- Hematology Product Demand by Application
- Blood Banking Product Demand by Type
- Blood Banking Product Demand by Application
- Hemostasis Product Demand by Type
- Hemostasis Product Demand by Application
- Nucleic Acid Testing Product Demand by Type
- Nucleic Acid Testing Product Demand by Application
- Microbiology Product Demand by Type
- Microbiology Product Demand by Application
- Cellular Analysis Product Demand by Methodology
- Flow Cytometry Product Demand by Type
- Flow Cytometry Product Demand by Application
- Other Cellular Analysis Product Demand by Type
- Other Cellular Analysis Product Demand by Application
- Other IVD Product Demand by Methodology
- Anatomical Pathology Product Demand by Type
- Anatomical Pathology Product Demand by Application
- Effusion & Visual Inspection Product Demand by Type
- Effusion & Visual Inspection Product Demand by Application
- Cytology Product Demand by Type
- Cytology Product Demand by Application
SECTION IV -- IVD APPLICATIONS
- IVD Product Demand by Application
- Endocrine Testing -- IVD Product Demand by Methodology & Condition
- Infectious Disease Testing -- IVD Product Demand by Condition
- Sexually Transmitted Disease (STD) Testing -- IVD Product Demand by
Methodology
- Sexually Transmitted Disease (STD) Testing -- IVD Product Demand by
Condition
- Other Infectious Disease Testing -- IVD Demand by Methodology
- Cancer Testing -- IVD Product Demand by Methodology
- Cancer Testing -- IVD Product Demand by Condition
- Drug Testing -- IVD Product Demand by Methodology & Type
- Heart Disease Testing -- IVD Product Demand by Methodology
- Blood Grouping & Screening -- IVD Product Demand by Methodology
- Forensic & Related Testing -- IVD Product Demand by Methodology
- General Health Screening & Other Applications -- IVD Product Demand by
Methodology & Procedure
SECTION V -- IVD MARKETS
- IVD Product Demand by Market
- Hospital Laboratory IVD Product Demand
- Independent Clinical Laboratory IVD Product Demand
- Home IVD Product Demand
- Outpatient IVD Product Demand
- Other Markets: IVD Product Demand
SECTION VI -- INDUSTRY STRUCTURE
- US IVD Product Sales by Company, 2008
- Selected Acquisitions & Divestitures
- Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- IVD PRODUCTS
- IVD Product Demand by Methodology, 2008
SECTION IV -- IVD APPLICATIONS
- IVD Product Demand by Application, 2008
SECTION V -- IVD MARKETS
- IVD Product Demand by Market, 2008
SECTION VI -- INDUSTRY STRUCTURE
- US IVD Product Sales, Market Share by Company, 2008
|
